Onco-Innovations Limited (NEO:ONCO)
Canada · Delayed Price · Currency is CAD 0.2000
0.00 (0.00%)
Nov 6, 2026, 12:33 PM EST
Onco-Innovations Market Cap
Onco-Innovations has a market cap or net worth of CAD 13.84 million as of November 6, 2026. It is the 41,463rd most valuable company in the world and the 1,429th biggest in Canada. Its market cap has decreased by 85.32% in one year.
Market Cap
13.84M
Enterprise Value
14.01M
Revenue
90.88K
Global Rank
Country Rank
#1,429 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since November 27, 2024, Onco-Innovations's market cap has decreased from 28.39M to 13.84M, a decrease of -51.23%. That is a compound annual growth rate of -30.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 13.84M | -81.74% |
| Dec 30, 2025 | 75.84M | 115.86% |
| Dec 31, 2024 | 35.13M | 23.76% |
| Nov 27, 2024 | 28.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Devonian Health Group | 18.77M |
| Pharmala Biotech Holdings | 17.55M |
| Rapid Dose Therapeutics | 14.47M |
| Lobe Sciences | 13.58M |
| PreveCeutical Medical | 12.76M |
| Britannia Life Sciences | 11.52M |
| Hemostemix | 10.57M |
| Alzai Health | 10.37M |